An examination of therapeutic synergy: a comprehensive meta-analysis comparing the efficacy of TAS-102 and FOLFOX as a combination therapy for colon cancer
This project report is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2024.
| Egile nagusia: | |
|---|---|
| Beste egile batzuk: | |
| Formatua: | Project report |
| Hizkuntza: | English |
| Argitaratua: |
Brac University
2024
|
| Gaiak: | |
| Sarrera elektronikoa: | http://hdl.handle.net/10361/23720 |
| id |
10361-23720 |
|---|---|
| record_format |
dspace |
| spelling |
10361-237202024-08-12T21:03:46Z An examination of therapeutic synergy: a comprehensive meta-analysis comparing the efficacy of TAS-102 and FOLFOX as a combination therapy for colon cancer Hasan, Amit Jamiruddin, Mohd. Raeed School of Pharmacy, Brac University Cancer therapy TAS-102 FOLFOX Colon cancer Progression-free survival Therapeutic synergy Colon (Anatomy)--Cancer Cancer--Treatment This project report is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2024. Cataloged from the PDF version of project report. Includes bibliographical references (pages 25-30). The treatment of colon cancer is a major healthcare issue that requires exploration of several treatment approaches. With an emphasis on overall survival, progression-free survival, and adverse events, this meta-analysis attempts to evaluate the efficacy and safety of TAS-102 and FOLFOX as a combination medication. The findings show that TAS-102 and FOLFOX both improve overall and progression-free survival, but that TAS-102 is more effective in the latter regard. There are significant variations in safety profiles between FOLFOX and TAS-102. TAS-102 shows better results, such as smaller confidence intervals and less severe side effects. The analyzed research indicates minimal publication bias. It is imperative to proceed with caution when generalizing these results to other demographic analysis. Amit Hasan B. Pharmacy 2024-08-12T04:16:08Z 2024-08-12T04:16:08Z ©2024 2024-02 Project report ID 18346085 http://hdl.handle.net/10361/23720 en Brac University project reports are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission. 47 pages application/pdf Brac University |
| institution |
Brac University |
| collection |
Institutional Repository |
| language |
English |
| topic |
Cancer therapy TAS-102 FOLFOX Colon cancer Progression-free survival Therapeutic synergy Colon (Anatomy)--Cancer Cancer--Treatment |
| spellingShingle |
Cancer therapy TAS-102 FOLFOX Colon cancer Progression-free survival Therapeutic synergy Colon (Anatomy)--Cancer Cancer--Treatment Hasan, Amit An examination of therapeutic synergy: a comprehensive meta-analysis comparing the efficacy of TAS-102 and FOLFOX as a combination therapy for colon cancer |
| description |
This project report is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2024. |
| author2 |
Jamiruddin, Mohd. Raeed |
| author_facet |
Jamiruddin, Mohd. Raeed Hasan, Amit |
| format |
Project report |
| author |
Hasan, Amit |
| author_sort |
Hasan, Amit |
| title |
An examination of therapeutic synergy: a comprehensive meta-analysis comparing the efficacy of TAS-102 and FOLFOX as a combination therapy for colon cancer |
| title_short |
An examination of therapeutic synergy: a comprehensive meta-analysis comparing the efficacy of TAS-102 and FOLFOX as a combination therapy for colon cancer |
| title_full |
An examination of therapeutic synergy: a comprehensive meta-analysis comparing the efficacy of TAS-102 and FOLFOX as a combination therapy for colon cancer |
| title_fullStr |
An examination of therapeutic synergy: a comprehensive meta-analysis comparing the efficacy of TAS-102 and FOLFOX as a combination therapy for colon cancer |
| title_full_unstemmed |
An examination of therapeutic synergy: a comprehensive meta-analysis comparing the efficacy of TAS-102 and FOLFOX as a combination therapy for colon cancer |
| title_sort |
examination of therapeutic synergy: a comprehensive meta-analysis comparing the efficacy of tas-102 and folfox as a combination therapy for colon cancer |
| publisher |
Brac University |
| publishDate |
2024 |
| url |
http://hdl.handle.net/10361/23720 |
| work_keys_str_mv |
AT hasanamit anexaminationoftherapeuticsynergyacomprehensivemetaanalysiscomparingtheefficacyoftas102andfolfoxasacombinationtherapyforcoloncancer AT hasanamit examinationoftherapeuticsynergyacomprehensivemetaanalysiscomparingtheefficacyoftas102andfolfoxasacombinationtherapyforcoloncancer |
| _version_ |
1814308846747779072 |